Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Developing human skin has immune cells with memory-like features.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Innate lymphoid cells help us understand and manage allergic diseases better.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Vitiligo and alopecia areata may have similar causes despite their differences.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Pantethine may boost the immune system's ability to fight sarcoma.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.